GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » YoY EBITDA Growth

Aelis Farma (XPAR:AELIS) YoY EBITDA Growth : 21.81% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aelis Farma's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 21.81%.

Aelis Farma's EBITDA per Share for the six months ended in Dec. 2023 was €-0.23.


Aelis Farma YoY EBITDA Growth Historical Data

The historical data trend for Aelis Farma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma YoY EBITDA Growth Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -16.12 5.36 167.33 -686.63 70.04

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only -111.04 -269.96 13.37 87.18 21.81

Aelis Farma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aelis Farma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.355--1.185)/ | -1.185 |
=70.04 %

Aelis Farma's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.233--0.298)/ | -0.298 |
=21.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Aelis Farma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines